Security key
92511W108
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA)
CUSIP: 92511W108
Q1 2020 13F Holders as of 31 Mar 2020
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 92,448,158
- Total 13F shares
- 8,833,450
- Share change
- -353,276
- Total reported value
- $96,547,906
- Price per share
- $10.93
- Number of holders
- 45
- Value change
- -$4,771,475
- Number of buys
- 16
- Number of sells
- 23
Report period
Q1 2020
Institutions
45
Top holders
10
VRCA full security history
Newer quarter: Q2 2020
Previous quarter: Q4 2019
Verrica Pharmaceuticals Inc. SEC filings
Verrica Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92511W108
Recent filing periods:
Top shareholders of VRCA - Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
3.7%
|
3,410,412
|
$52,022,000 | — | 31 Dec 2019 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.6%
|
1,479,733
|
$23,513,000 | — | 31 Dec 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.79%
|
727,265
|
$11,556,000 | — | 31 Dec 2019 | |
| FMR LLC |
13F
|
Company |
0.69%
|
635,680
|
$10,101,000 | — | 31 Dec 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.62%
|
572,438
|
$9,096,000 | — | 31 Dec 2019 | |
| KORNITZER CAPITAL MANAGEMENT INC /KS |
13F
|
Company |
0.48%
|
444,531
|
$7,064,000 | — | 31 Dec 2019 | |
| Fosun International Ltd |
13F
|
Company |
0.45%
|
412,869
|
$6,560,000 | — | 31 Dec 2019 | |
| STATE STREET CORP |
13F
|
Company |
0.24%
|
224,524
|
$3,568,000 | — | 31 Dec 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.18%
|
163,235
|
$2,593,000 | — | 31 Dec 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.15%
|
141,135
|
$2,243,000 | — | 31 Dec 2019 | |
| SteelPeak Wealth, LLC |
13F
|
Company |
0.14%
|
132,361
|
$2,103,000 | — | 31 Dec 2019 | |
| CONNING INC. |
13F
|
Company |
0.14%
|
129,013
|
$2,050,000 | — | 31 Dec 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.11%
|
103,427
|
$1,644,000 | — | 31 Dec 2019 | |
| Spouting Rock Asset Management, LLC |
13F
|
Company |
0.08%
|
75,709
|
$1,203,000 | — | 31 Dec 2019 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.06%
|
52,093
|
$828,000 | — | 31 Dec 2019 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.05%
|
46,265
|
$735,000 | — | 31 Dec 2019 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.04%
|
41,345
|
$657,000 | — | 31 Dec 2019 | |
| ZACKS INVESTMENT MANAGEMENT |
13F
|
Company |
0.04%
|
38,126
|
$606,000 | — | 31 Dec 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.04%
|
35,743
|
$568,000 | — | 31 Dec 2019 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.04%
|
33,393
|
$531,000 | — | 31 Dec 2019 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.03%
|
28,839
|
$459,000 | — | 31 Dec 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
21,852
|
$347,000 | — | 31 Dec 2019 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.02%
|
20,852
|
$331,000 | — | 31 Dec 2019 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
20,781
|
$330,000 | — | 31 Dec 2019 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.02%
|
19,400
|
$308,000 | — | 31 Dec 2019 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
18,714
|
$298,000 | — | 31 Dec 2019 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.02%
|
17,323
|
$275,000 | — | 31 Dec 2019 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
17,227
|
$274,000 | — | 31 Dec 2019 | |
| Capital Investment Advisory Services, LLC |
13F
|
Company |
0.02%
|
14,125
|
$224,000 | — | 31 Dec 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.02%
|
13,900
|
$221,000 | — | 31 Dec 2019 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.01%
|
13,800
|
$219,000 | — | 31 Dec 2019 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
12,889
|
$205,000 | — | 31 Dec 2019 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
11,670
|
$185,000 | — | 31 Dec 2019 | |
| David M. Knott |
13F
|
Individual |
0.01%
|
10,207
|
$162,000 | — | 31 Dec 2019 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.01%
|
10,100
|
$160,000 | — | 31 Dec 2019 | |
| BECK MACK & OLIVER LLC |
13F
|
Company |
0.01%
|
10,000
|
$159,000 | — | 31 Dec 2019 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
8,073
|
$128,000 | — | 31 Dec 2019 | |
| BESSEMER GROUP INC |
13F
|
Company |
0.01%
|
5,000
|
$79,000 | — | 31 Dec 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0%
|
4,449
|
$69,000 | — | 31 Dec 2019 | |
| MEEDER ASSET MANAGEMENT INC |
13F
|
Company |
0%
|
4,304
|
$69,000 | — | 31 Dec 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
4,227
|
$67,000 | — | 31 Dec 2019 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
2,605
|
$41,393 | — | 31 Dec 2019 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
2,585
|
$41,000 | — | 31 Dec 2019 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
2,476
|
$39,000 | — | 31 Dec 2019 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
2,161
|
$34,000 | — | 31 Dec 2019 | |
| STRS OHIO |
13F
|
Company |
0%
|
1,700
|
$27,000 | — | 31 Dec 2019 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0%
|
1,637
|
$26,000 | — | 31 Dec 2019 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
1,080
|
$17,000 | — | 31 Dec 2019 | |
| Squar Milner Financial Services LLC |
13F
|
Company |
0%
|
1,005
|
$15,000 | — | 31 Dec 2019 | |
| Realta Investment Advisors |
13F
|
Company |
0%
|
400
|
$6,000 | — | 31 Dec 2019 |
Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) as of Q1 2020
As of 31 Mar 2020,
Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value (VRCA) was held by
45 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,833,450 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, ORBIMED ADVISORS LLC, BlackRock Inc., FMR LLC, VANGUARD GROUP INC, KORNITZER CAPITAL MANAGEMENT INC /KS, Fosun International Ltd, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, and NORTHERN TRUST CORP.
This page lists
45
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2020 vs Q4 2019 Across Filers
Q4 2019 holders
52
Q1 2020 holders
45
Holder diff
-7
| Investor | Q4 2019 Shares | Q1 2020 Shares | Share Diff | Share Chg % | Q4 2019 Value $ | Q1 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.